24/7 Market News Snapshot 02 July, 2025 – Nutriband Inc. Common Stock (NASDAQ:NTRB)

July 2, 2025

DENVER, Colo., 02 July, 2025 (www.247marketnews.com) – (NASDAQ:NTRB) are discussed in this article.
Nutriband Inc. (NTRB) has captured substantial investor interest, as evidenced by a remarkable surge in stock price, opening at $9.11 and climbing to $10.768—a notable increase of 34.26%. This rise follows a prior closing price of $8.020, heralding a strong bullish trend and drawing significant trading volume of 604.82K. The heightened interest suggests a growing anticipation around Nutriband’s innovative solutions and their potential to captivate the market further.

Amidst this backdrop, Nutriband has announced a pivotal decision by its Board of Directors to implement a 25% preferred stock dividend aimed at bolstering shareholder value. Beginning July 25, 2025, for every four shares of common stock held, shareholders will receive one preferred share, with new shares issued on August 5, 2025. This initiative is designed to enhance shareholder engagement as the company approaches significant advancements in its transdermal pharmaceutical technologies.

CEO Gareth Sheridan emphasized Nutriband’s commitment to creating lasting value, particularly as it gears up for the commercialization of its groundbreaking AVERSA™ fentanyl product, which features advanced abuse-deterrent technology. Upon obtaining FDA approval, preferred shares will be convertible into common shares, aligning shareholder interests with the company’s growth trajectory.

The AVERSA™ technology aims to integrate aversive agents into transdermal patches, thereby minimizing the potential for abuse and misuse of drugs like fentanyl. With a robust intellectual property portfolio safeguarding its innovations across major global markets, Nutriband is poised to redefine the safety and effectiveness of transdermal medications. As the company continues its journey towards commercialization, it remains focused on enhancing patient care while addressing critical concerns surrounding drug abuse.

Related news for (NTRB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.